SCHEMBL4811680

SCHEMBL4811680

FC(F)(F)c1ccc2nc(-c3cccc(-c4ccccn4)n3)[nH]c2c1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CBFB Q13951 9/20 0.85
METAP2 P50579 7/20 0.65
NPBWR1 P48145 1/20 0.60
METAP1 P53582 5/20 0.59
RUNX1 Q01196 2/20 0.58
DGAT1 O75907 1/20 0.57
KCNH2 Q12809 1/20 0.57
NPC1 O15118 5/20 0.55
RAB9A P51151 5/20 0.55
PKM P14618 4/20 0.55
LMNA P02545 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
HPGD P15428 2/20 0.55
KDM4E B2RXH2 2/20 0.55
MAPT P10636 2/20 0.55
TP53 P04637 1/20 0.55
GAA P10253 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
BACE1 P56817 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4814508 0.90 CBFB (0.69) CBFBMETAP2NPBWR1METAP1RUNX1
SCHEMBL4189664 0.85 CBFB (0.81) CBFBMETAP2NPBWR1DGAT1KCNH2
SCHEMBL4812344 0.83 CBFB (0.84) CBFBMETAP2METAP1RUNX1NPC1
SCHEMBL179138 0.82 CBFB (0.80) CBFBMETAP2NPBWR1METAP1RUNX1
SCHEMBL4814803 0.81 METAP2 (0.84) CBFBMETAP2METAP1RUNX1NPC1
SCHEMBL4808230 0.80 METAP2 (0.81) CBFBMETAP2METAP1NPC1RAB9A
SCHEMBL4176876 0.79 CBFB (0.71) CBFBMETAP2NPBWR1METAP1RUNX1
SCHEMBL4815533 0.79 CBFB (0.84) CBFBMETAP2METAP1RUNX1NPC1
SCHEMBL4188605 0.78 CBFB (0.69) CBFBMETAP2NPBWR1METAP1DGAT1
Hydrochloric Acid SCHEMBL4812284 0.78 METAP2 (0.79) CBFBMETAP2METAP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7459457-B2 Polycyclic pyridines as potassium ion channel modulators ICAGEN, INC. (US) 2008-12-02 US disclosed
US-20050227958-A1 Polycyclic pyridines as potassium ion channel modulators ICAGEN, INC. (US) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227958-A1 Polycyclic pyridines as potassium ion channel modulators KCNJ2, KCNH2, KCNQ1 CBFB 3514/4885METAP2 4135/4885NPBWR1 2809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.